PREVALENCE OF SEROLOGIC TESTS ANTI HCV ON CHRONIC KIDNEY DISEASE (CKD) PATIENTS IN THE HEMODIALYSIS CLINIC PMI OF SURAKARTA CITY

Abstract

Patients Chronic Kidney Disease (CKD) undergoing hemodialysis therapy classified as a high-risk group infected with the hepatitis C virus Type of research is to study the design retrospeksif. This research was conducted at the Clinic Hemodialysis PMI Surakarta. The study population was all patients with Chronic Kidney Disease (CKD) with HCV serologic test results were undergoing hemodialysis at the Hemodialysis Clinic Surakarta PMI indicates a reactive result. The research sample is CKD patients undergoing hemodialysis infected with chronic hepatitis C virus in Hemodialysis Clinic PMI Surakarta. In the results showed a group of men more prevalence of HCV serologic tests (53%) than among women (47%), the age groups most positive for HCV serologic results are above 60 years as many as 6 people (35%). It is essential for the screening of anti HCV in CKD patients on hemodialysis time before action in a Hemodialisism Services unit, and evaluated periodically depending on the policy of each hemodialysis care unit. Also to reduce the prevalence of nosocomial infections, health workers always carry out universal precautions.